Daawaynta kacaanku waxa ay noqon kartaa daawaynta ugu waxtarka badan ee leukemia-da soo laabatay

Mid ka mid ah dhakhaatiirta ugu horreeya adduunka ee cilmi-nafsiga ayaa aaminsan in daawaynta cusub ee difaaca jirka ee loogu yeero "daawoyinka nool" ay noqon karaan "hubka ugu waxtarka badan ee horumarsan ee la dagaallanka kansarka", oo bixiya horumar la taaban karo oo heerarka badbaadada.

Dr. Rabih Hanna, oo ku taqasusay cudurrada dhiiga carruurta, ku takhasusay cudurrada kansarka iyo dhuuxa lafta oo ku takhasusay Cleveland Clinic ee Maraykanka, oo booqanaysa bandhigga iyo shirka caafimaadka Carabta ee hadda ka socda Dubai, ayaa sheegtay in daawaynta la isticmaalayo kimeric reseptors ee unugyada T, oo loo yaqaan. sida "karti" Gawaarida TWaxay ku salaysan tahay in unugyada T laga soo saaro jidhka bukaanka oo ay hidde ahaan wax ka beddelaan shaybaarka si ay u weeraraan unugyada kansarka.

Dhiiga bukaanka ayaa la qaadaa waxaana shaybaadh lagu sameeyaa unugyada T, kuwaas oo ah nooca unugyada difaaca, si ay u awoodaan inay weeraraan oo ay dilaan unugyada kansarka. Unugyada Karti ee la bedelay waxa laga galaa jidhka bukaanka dhiigga, muddo 14 maalmood ah oo daaweyn ah.

Cleveland Clinic Children's waa mid ka mid ah isbitaallada ugu horreeya ee bixiya daawaynta T-cell ee carruurta qaba kansarka, daawaynta dhowaan loo oggolaaday in lagu isticmaalo Mareykanka iyo Yurub.

Dr. Hanna waxay carrabka ku dhufatay natiijooyinka hore ee isticmaalka daawaynta reseptor T-cell (Karti) ee daawaynta carruurta iyo dadka da'da yar ee qaba kansarka leukemia ba'an ee ka-hor-B-cell. BNooc gaar ah oo lymphoma ah DLBCL (Lymphoma weyn oo lagu faafiyay B-cell) "waa rajo iyo xiiso leh," isagoo ku sifeeyay daawaynta inay tahay "daawoyinka shakhsi ahaaneed ee ugu dambeeya ee loogu talagalay in lagula dagaallamo leukemia weligeed" sababtoo ah waxay ku sii jirtaa dhiigga sida daawo nool, waxayna ku dartay: "T-cell therapy waxay bixisaa Awood weyn oo loogu talagalay daawaynta leukemia, maaha Gaar ahaan bukaanka da'doodu ka yar tahay 26 jir ee dib u soo noqoshada leukemia ba'an.

Khudbadii uu ka jeediyay shirka caafimaadka Carabta, Dr. Hanna ayaa loo qorsheeyay inay wax ka qabato caqabadaha iyo fursadaha daaweynta kansarka ee carruurta, dhalinyarada iyo dhalinyarada. Waxa uu aaminsan yahay in waxtarka daaweynta T-cell ay caddayn karto xitaa dadka qaangaarka ah ee aan Hodgkin ee weyn ee B-cell lymphoma.

Waxayna Dr. Hanna ku soo gabagabaysay iyadoo leh: "Waxaan hadda aragnaa boodbood ballaaran oo heerarka badbaadada, oo wadar ahaan 70 ama 80 boqolkiiba."

Sida laga soo xigtay Dr. Hanna, daawaynta T-cell ayaa hadda loo sameeyay si loo daweeyo kansarka kale ee dhiigga, sida lymphocytic leukemia raaga iyo noocyada kale ee lymphoma iyo multiple myeloma.

Shirweynaha 28-aad ee caafimaadka Carabta waxa lagu qaban doonaa inta u dhaxaysa 31-XNUMX January ee Dubai World Trade Center iyo Conrad Dubai Hotel.